Commentary on "A review of new drugs approved by the food and drug administration in 2022"

J Family Med Prim Care. 2024 Mar;13(3):1133. doi: 10.4103/jfmpc.jfmpc_1833_23. Epub 2024 Apr 4.
No abstract available